Search Results
Baxter Expands Cybersecurity Commitment, Joins Forces with U.S. Cybersecurity and Infrastructure Security Agency (CISA) Led Program
Baxter International Inc. (NYSE:BAX), a leading global medtech leader, announced that it has received authorization from the Common Vulnerability and Exposures (CVE®) program to be a CVE Numbering Authority. As a CVE Numbering Authority (CNA), Baxter is responsible for the assignment of CVE identifiers to cyber vulnerabilities for Baxter and Hillrom commercially available products, and for publicly disclosing information about the vulnerabilities in the associated CVE Record.
Baxter to Present at the Raymond James 43rd Annual Institutional Investors Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James 43rd Annual Institutional Investors Conference on Monday, March 7, 2022. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 8:40 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through March 6, 2023.
Baxter Reports Fourth-Quarter and Full-Year 2021 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2021, and provided its financial guidance for full-year and first-quarter 2022. Fourth-quarter and full-year 2021 results reflect 19 days of contribution from Hillrom Holdings, Inc. (Hillrom) subsequent to Baxter’s acquisition of the company on Dec. 13, 2021.
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock. The dividend is payable on April 1, 2022, to shareholders of record as of Feb. 25, 2022. The indicated annual dividend rate is $1.12 per share of common stock. About Baxter
Baxter to Present at Citi's 2022 Virtual Healthcare Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23, 2022. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 1:15 p.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through February 22, 2023. About Baxter
Giving Back on our Day of Service
Baxter honors Dr. King's legacy through service to the community
Thurgood Marshall College Fund and the Baxter International Foundation Partner on New $3.5 Million Minority Student Program
The Thurgood Marshall College Fund (TMCF), the largest organization exclusively representing the Black College community, and the Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), introduced today a new collaboration called the Baxter HBCU STEM Scholars Program.
Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2021 financial results on Thursday, February 17, 2022 at 7:30 a.m. Central Time. To participate in this conference call please follow this link http://www.directeventreg.com/registration/event/3168996 to pre-register for the call and receive the call information.
Leading a Healthy Working Environment
Seramount, a professional services firm dedicated to advancing diversity, equity, and inclusion in the workplace, named Baxter to its list of Top 75 Companies for Executive Women. We are committed to broadening representation of women at all levels, especially the advancement to leadership roles.
Baxter Completes Acquisition of Hillrom, Creating ~$15 Billion Global Medtech Leader
Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today it has completed its acquisition of Hillrom. Baxter paid $156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of $10.5 billion (based on Hillrom share counts at closing). Including the assumption of Hillrom's outstanding debt obligations, the enterprise value of the transaction is approximately $12.5 billion.